Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Sanguine
company
About
Sanguine develops innovative technology solutions for clinical researchers.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $224.98K
- Industries
- Apps,Biotechnology,Clinical Trials,Health Care,Life Science,Medical
- Founded date
- Jan 1, 2010
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Sanguine develops innovative technology solutions for clinical researchers. The company facilitates clinical trials by recruiting participants, conducting at-home data collection, and processing samples, enabling clinicians to prescribe the right medicines.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$2.22M
Sanguine has raised a total of
$2.22M
in funding over 2 rounds. Their latest funding was raised on
Feb 26, 2019 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 26, 2019 | Grant | $224.98K | 1 |
National Science Foundation
|
— | Detail |
| Feb 23, 2013 | Seed | $2M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Sanguine is funded by 2 investors.
National Science Foundation
and Heliant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Heliant Ventures
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
